This one comes to us from Peter Stansberry as part of an ad for his Phase 1 Investor service … which he’d like you to subscribe to in exchange for learning about this fabulous company in a special report.
In fact, he’s promising that his biotech analyst will reveal the name of this company on Thursday [...]
by Richard Balint on March 20, 2010 at 12:19 pm
by abrodie on March 20, 2010 at 11:33 am
by Vernon on March 19, 2010 at 5:10 pm
by stockcrazy10 on March 19, 2010 at 8:16 am
by stockcrazy10 on March 19, 2010 at 1:05 am